Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-02-03 @ 2:03 AM
Study NCT ID:
NCT01316718
Status:
COMPLETED
Last Update Posted:
2014-01-17
First Post:
2010-09-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
Sponsor:
Organization: